Keyphrases
Acute Lung Injury
24%
Alisertib
24%
Allogeneic
24%
Anti-RBD IgG
24%
Anti-spike IgG
24%
Assembly Cell
24%
Aurora Kinase A (AURKA)
35%
Biological Efficacy
48%
Boron Neutron Capture Therapy
48%
Cell Proliferation
26%
ChAdOx1 nCov-19 Vaccination
24%
Dysregulation
24%
E3 Ubiquitin Ligase
50%
EGF Receptor
24%
Enhanced Cancer Therapy
48%
Epithelial Growth Factor Receptor Tyrosine Kinase Inhibitor
24%
Expression Pattern
26%
Hepatitis delta Antigen
48%
Hepatitis delta Virus
33%
Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs)
24%
Humoral Antibody Response
24%
Humoral Immunogenicity
24%
IgG Levels
32%
Induced Degradation
24%
Inflammation
29%
Lipopolysaccharide-induced Inflammation
24%
Lung Adenocarcinoma
72%
Lung Squamous Cell Carcinoma
24%
Macrophages
24%
Microfluidic-based
24%
Non-small Cell Lung Cancer (NSCLC)
100%
Palbociclib
48%
Pancreatic Tumor
29%
Phosphorylation
50%
Polymerase II
24%
Processive
24%
Pulmonary Fibrosis
24%
Reactogenicity
28%
RNA Replication
48%
RNA-dependent RNA Polymerase (RdRP)
24%
Seroconversion Rate
30%
SHP-1
24%
Survival Analysis
24%
Tensin
55%
Three-dimensional Self-assembly
24%
Tumor Spheroids
24%
Tumorigenicity
28%
Uterine Smooth muscle Tumor of Uncertain Malignant Potential
24%
Vaccination
48%
Viral
24%
Biochemistry, Genetics and Molecular Biology
Antibody Response
24%
Aurora A Kinase
36%
Binding Domain
12%
Biological Activity
8%
C-Terminus
54%
Cadherin
8%
Cancer Cell
27%
Cancer Mortality
8%
Cell Migration
9%
Cell Proliferation
30%
Cladistics
24%
Colon
8%
Cre Recombinase
8%
Downregulation
24%
Epidermal Growth Factor Receptor
57%
Expression Analysis
24%
Fibroblast
26%
Focal Adhesion
18%
Galactosidase
8%
Genomics
9%
Growth Factor Receptor
24%
Hemodialysis
24%
Hepatitis D
48%
Hepatitis Delta Virus
33%
Immunogenicity
32%
Isoform
30%
Mesenchymal-Epithelial Transition
24%
Messenger RNA
34%
Mouse Model
8%
Neutron Radiation
8%
Phylogeny
24%
Programmed Cell Death
10%
Promoter Region
24%
Receptor Binding
12%
Receptor Tyrosine Kinase Inhibitors
24%
Rigidity
8%
RNA
18%
RNA Polymerase
24%
RNA Polymerase II
16%
RNA Replication
48%
SARS Coronavirus
20%
Serine
48%
Seroconversion
30%
Spike
24%
Survival Rate
14%
Tensin
64%
Tumor Spheroid
48%
Ubiquitin-Conjugating Enzyme
50%
Ubiquitination
10%
Upregulation
24%